CF
PFE icon

Copperwynd Financial’s Pfizer PFE Stock Holding History

Copperwynd Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,935
Closed -$670K – 151
2024
Q2 		$670K Buy
21,935
+2,724
+14% +$75K 0.22% 94
2024
Q1 		$533K Buy
19,211
+5,153
+37% +$143K 0.19% 99
2023
Q4 		$405K Sell
14,058
-305
-2% -$9.22K 0.16% 104
2023
Q3 		$476K Sell
14,363
-883
-6% -$31.2K 0.22% 91
2023
Q2 		$559K Buy
15,246
+967
+7% +$37.6K 0.26% 93
2023
Q1 		$583K Buy
14,279
+204
+1% +$8.81K 0.3% 77
2022
Q4 		$721K Sell
14,075
-229
-2% -$11K 0.41% 57
2022
Q3 		$626K Sell
14,304
-1,188
-8% -$57.7K 0.36% 55
2022
Q2 		$812K Sell
15,492
-44,002
-74% -$2.24M 0.48% 44
2022
Q1 		$3.08M Sell
59,494
-63,275
-52% -$3.28M 1.28% 17
2021
Q4 		$7.25M Buy
122,769
+109,434
+821% +$5.42M 2.75% 8
2021
Q3 		$574K Buy
13,335
+628
+5% +$27.8K 0.24% 85
2021
Q2 		$498K Sell
12,707
-849
-6% -$33K 0.21% 98
2021
Q1 		$491K Buy
13,556
+84
+0.6% +$2.98K 0.22% 88
2020
Q4 		$496K Sell
13,472
-32
-0.2% -$1.17K 0.24% 74
2020
Q3 		$470K Sell
13,504
-275
-2% -$9.64K 0.25% 64
2020
Q2 		$427K Sell
13,779
-947
-6% -$32.2K 0.24% 68
2020
Q1 		$456K Buy
14,726
+2,236
+18% +$76.2K 0.22% 41
2019
Q4 		$464K Sell
12,490
-1,616
-11% -$57.6K 0.25% 87
2019
Q3 		$494K Buy
14,106
+2,354
+20% +$85.6K 0.28% 80
2019
Q2 		$483K Sell
11,752
-38
-0.3% -$1.51K 0.28% 59
2019
Q1 		$475K Sell
11,790
-989
-8% -$39.6K 0.28% 55
2018
Q4 		$529K Sell
12,779
-2,250
-15% -$93.4K 0.33% 29
2018
Q3 		$628K Buy
+15,029
New +$579K 0.38% 36

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Copperwynd Financial's PFE Position: Q3 2024 in Review

Copperwynd Financial sold out of Pfizer (PFE) in Q3 2024, closing a stake of 21,935 shares — an estimated $670K sold.

Copperwynd Financial first reported a position in PFE in Q3 2018 and held it in 24 quarters. The position peaked at $7.25M in Q4 2021. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Copperwynd Financial reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Copperwynd Financial sold 21,935 Pfizer shares in Q3 2024, an estimated $670K.
  • Copperwynd Financial first reported a position in Pfizer in Q3 2018 and held it in 24 quarters.
  • Copperwynd Financial's Pfizer position peaked at $7.25M in Q4 2021.
  • 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Copperwynd Financial's 13F filing for Q3 2024, filed 4 Nov 2024.